Interleukin‐34 Reprograms Glycolytic and Osteoclastic Rheumatoid Arthritis Macrophages via Syndecan 1 and Macrophage Colony‐Stimulating Factor Receptor
Katrien Van Raemdonck(Rega Institute for Medical Research), Shiva Shahrara(University of Illinois Chicago), Chandana Tetali(University of Illinois Chicago), Karol Palasiewicz(University of Illinois Chicago), Sadiq Umar(University of Illinois Chicago), Hatem A. Elshabrawy(Sam Houston State University), Michael V. Volin(Midwestern University), Nadera Sweiss(University of Illinois Chicago), Azam Ahmed(University of Illinois Chicago), Bianca Romay(University of Illinois Chicago), M. Asif Amin(University of Michigan), Ryan K. Zomorrodi(University of Illinois Chicago)
Cited by 49
Related Papers
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
|PubMed|2014|505
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
Racial Difference in Sarcoidosis Mortality in the United States
|CHEST Journal|2014|251
Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction
|Circulation Cardiovascular Imaging|2016|217